With particular expertise in proven medical innovations addressing global markets.
At a time when healthcare systems around the world are under increasing pressure to deliver higher quality care at lower cost, the HealthTech sector is at the forefront of delivering proven medical innovations to improve patient outcomes while increasing efficiency of the healthcare system.
Innovations in health technologies build on decades of progress in mature sectors of micro-electronics, material science, and information technology to offer new treatment paradigms. Innovative companies are actively meeting the challenges of growing demand for improved patient outcomes and increased efficiency by bringing new medical innovations to global markets.
Salus Partners specializes in investments within the HealthTech sector that can provide attractive risk-adjusted returns to investors. We are actively investing in:
- Specialized Private Equity funds
- Privately held companies through Direct and Co-Investments
- Publicly quoted micro-caps and small-caps
A team with meta perspectives
Salus Partners is a regulated investment firm with special expertise in health technology innovation. Based on our decades of experience and deep understanding of economic trends and emerging innovation, we devise winning investment strategies and exceptional returns. Drawing on deep sector knowledge and decades of experience in the industry we actively support companies to efficiently realize their potential in bringing proven medical innovation into global markets.
For investors and Family Offices we provide unique opportunities to participate in growth of proven health technology companies with full life cycle management of investments including:
- Micro-cap and small-cap quoted companies
- Private Equity Fund due diligence and subscription
- Identification and due diligence of promising growth companies for direct and co-investments
- Board representation for governance and risk management